|
Volumn 40, Issue 3, 2010, Pages 631-634
|
The NLRP3 inflammasome, a target for therapy in diverse disease states
|
Author keywords
Autoinflammatory; Cancer; IL 1 inhibition; Inflammasome; Liver
|
Indexed keywords
ACETYLSALICYLIC ACID;
ALLERGEN;
CANAKINUMAB;
CRYOPYRIN;
CYTOKINE;
GLUCOSE;
INFLAMMASOME;
INTERLEUKIN 1;
INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;
INTERLEUKIN 1BETA;
INTERLEUKIN 1BETA ANTIBODY;
INTERLEUKIN 6;
METHOTREXATE;
MONOCLONAL ANTIBODY;
PARACETAMOL;
PROTEIN;
RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;
RILONACEPT;
THALIDOMIDE;
TUMOR NECROSIS FACTOR;
UNCLASSIFIED DRUG;
XOMA 052;
AUTOIMMUNE DISEASE;
AUTOINFLAMMATORY DISEASE;
CINCA SYNDROME;
CONTACT DERMATITIS;
CYTOKINE PRODUCTION;
DIABETES MELLITUS;
DRUG TARGETING;
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME;
FAMILIAL MEDITERRANEAN FEVER;
GENE MUTATION;
GOUT;
HUMAN;
IMMUNOTHERAPY;
INFLAMMATION;
LIVER FIBROSIS;
LIVER TOXICITY;
MONOTHERAPY;
MUCKLE WELLS SYNDROME;
MYELOMA;
NEOPLASM;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NONHUMAN;
PRIORITY JOURNAL;
PSEUDOGOUT;
REVIEW;
RHEUMATOID ARTHRITIS;
SKIN ALLERGY;
TREATMENT OUTCOME;
ANIMALS;
AUTOIMMUNE DISEASES;
CARRIER PROTEINS;
DERMATITIS, CONTACT;
DIABETES MELLITUS, TYPE 2;
HUMANS;
IMMUNITY, INNATE;
INFLAMMATION;
MULTIPROTEIN COMPLEXES;
NEOPLASMS;
|
EID: 77749245838
PISSN: 00142980
EISSN: 15214141
Source Type: Journal
DOI: 10.1002/eji.200940162 Document Type: Review |
Times cited : (41)
|
References (45)
|